|
⚲
|
| Keyboard |
| Tayton-Martin Helen Katrina
✚
|
|
|---|---|
| CIK # | 0001661780 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001661780] | |
| 4 | [0001661780] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tayton-Martin Helen Katrina | |
| Adaptimmune Therapeutics PLC | |
| Trillium Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2024-01-15 | Grant | 2,544,432 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2024-01-15 | Grant | 565,416 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP]
Option to purchase Ordinary Shares · derivative
|
2023-01-17 | Grant | 197,064 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP]
Option to purchase Ordinary Shares · derivative
|
2023-01-17 | Grant | 314,256 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP]
Option to purchase Ordinary Shares · derivative
|
2023-01-17 | Grant | 1,407,072 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2022-01-12 | Grant | 1,407,072 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2022-01-12 | Grant | 314,256 | $0.00 | |
|
Trillium Therapeutics Inc TRIL
Stock Option (Right to Buy) · derivative
|
2021-11-17 | Disposed to issuer | 40,000 | $0.00 | |
|
Trillium Therapeutics Inc TRIL
Deferred Share Unit · derivative
|
2021-11-17 | Disposed to issuer | 498,294.29 | ||
|
Adaptimmune Therapeutics PLC ADAP
Ordinary Shares with a nominal value of GBP0.001 per share
|
2021-03-03 | Option exercise | 1,785,000 | $0.16 | 285,600 |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2021-01-11 | Grant | 1,086,816 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2021-01-11 | Grant | 242,712 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
American Depositary Shares
|
2020-08-03 | Sell | 200,000 | $8.74 | 1,748,000 |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2020-01-16 | Grant | 1,257,744 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2020-01-16 | Grant | 280,896 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
American Depositary Shares
|
2020-01-13 | Sell | 50,000 | $5.00 | 250,000 |
|
Adaptimmune Therapeutics PLC ADAP
American Depositary Shares
|
2020-01-13 | Sell | 50,000 | $4.00 | 200,000 |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2019-01-04 | Grant | 224,724 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2019-01-04 | Grant | 1,006,224 | $0.00 | |
|
Adaptimmune Therapeutics PLC ADAP
Option to purchase Ordinary Shares · derivative
|
2018-01-12 | Grant | 153,648 | $0.00 | |
| showing 20 of 23 most recent transactions | |||||